THOMSON ROBERT C
Known title: VP Research & DevelopmentCIK: 0001980521
Associated companies
Transaction History
| AORT | ▲ Buy | Grant | 8,165 | $0 | 2/23/2024 | View on chart |
| AORT | ▲ Buy | Grant | 5,126 | $79K | 6/9/2023 | View on chart |
| AORT | ▲ Buy | Grant | 8,165 | $0 | 2/23/2024 | View on chart |
| AORT | ▲ Buy | Grant | 5,126 | $79K | 6/9/2023 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Artivion Q2 2026 Earnings Call Transcript Released
Artivion has released the transcript for its Q2 2026 earnings conference call, providing detailed insights into recent performance. The stock is currently trading near its 52-week low, reflecting a significant decline from its high. Analysts maintain a higher average price target, suggesting a gap between current market sentiment and long-term expectations.
Artivion Q2 2026 Earnings Call Transcript Released. Artivion has released the transcript for its Q2 2026 earnings conference call, providing detailed insights into recent performance. The stock is currently trading near its 52-week low, reflecting a significant decline from its high. Analysts maintain a higher average price target, suggesting a gap between current market sentiment and long-term expectations.